Engineering Saccharomyces cerevisiae to produce plant benzylisoquinoline alkaloids

aBIOTECH. 2021;2(3):264-275. doi: 10.1007/s42994-021-00055-0. Epub 2021 Jul 18.

Abstract

Benzylisoquinoline alkaloids (BIAs) are a diverse family of plant natural products with extensive pharmacological properties, but the yield of BIAs from plant is limited. The understanding of BIA biosynthetic mechanism in plant and the development of synthetic biology enable the possibility to produce BIAs through microbial fermentation, as an alternative to agriculture-based supply chains. In this review, we discussed the engineering strategies to synthesize BIAs in Saccharomyces cerevisiae (yeast) and improve BIA production level, including heterologous pathway reconstruction, enzyme engineering, expression regulation, host engineering and fermentation engineering. We also highlight recent metabolic engineering advances in the production of BIAs in yeast.

Keywords: Benzylisoquinoline alkaloids (BIAs); Metabolic engineering; Saccharomyces cerevisiae; Synthetic biology.

Publication types

  • Review